Cargando…
Improving the operational efficiency of Phase 2 and 3 trials
The period toward the end of patients’ participation in late stage blinded clinical trials is highly resource intensive for the sponsor. Consider first a Phase 3 trial. If the trial is a success, the sponsor has to implement the next steps, which might be filing for approval of the drug with the US...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955134/ https://www.ncbi.nlm.nih.gov/pubmed/27439520 http://dx.doi.org/10.1186/s13063-016-1465-3 |